Heart failure is a growing health and economic burden in ageing populations. Symptoms are often non-specific and do not help to discriminate between HF and other problems. Both B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-proBNP) assist in making the diagnosis of HF and in determining its prognosis. In this webinar, you will learn the IFCC recommendations on the appropriate use, analytical performance, and gaps in clinical studies related to the use of natriuretic peptide (NP) assays.
Topic of Latest IFCC Recommendations: Natriuretic Peptides in HF
Appropriate use, analytical performance of Natriuretic Peptides assays
Clinical Aspects of Natriuretic Peptides with a Focus on Heart Failure
Why should you attend
Learning from sharing on the appropriate use, analytical performance, and gaps in clinical studies related to the use of natriuretic peptide (NP) assays
Learning from Clinician perspective on underlying biology of NP production and clearance in health and disease, as well as analytic issues that influence their clinical application, especially with regard to heart failure (HF)
Participate in Live Q&A session
Agenda:
